Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Sethuraman Natarajan
Over the trailing 90 days, Sethuraman Natarajan (Other Officer at Entrada Therapeutics, Inc.) sold $399K of stock in TRDA, per 1 SEC Form 4 transaction.
- Role
- Other Officer
- Companies
- TRDA
- Window
- Trailing 90 days · 1 transactions · CIK 1873394
- Net activity
- −$399K ($0 bought · $399K sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| TRDA | Entrada Therapeutics, Inc. | 1 | — | $399K | −$399K |
Transactions (1)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-05-04 | TRDA | Sell | 25.9K | $399K | Open market or private sale |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Sethuraman's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.